| Title |
Author |
Type |
Date |
Words |
| Kite Pharmas CAR T-cell Therapy Production Facility. |
|
|
May 20, 2019 |
283 |
| Syncona Establishes New Cell Therapy Firm With GBP35 Million Financing. |
|
|
May 20, 2019 |
220 |
| New findings could be used as vaccination strategy for sexually transmitted infections. |
|
|
May 18, 2019 |
425 |
| Portugal : First treatments with gene therapy of CAR T cells advance in Portugal. |
|
|
May 18, 2019 |
267 |
| Adaptimmune announces license agreement with Alpine Immune Sciences. |
|
|
May 15, 2019 |
168 |
| Shenfu injection prolongs survival and protects the intestinal mucosa in rats with sepsis by modulating immune response. |
Jin, Shuifang; Jiang, Ronglin; Lei, Shu; Jin, Liming; Zhu, Chen; Feng, Wen; Shen, Yingying |
Report |
May 11, 2019 |
4719 |
| Tmunity Therapeutics signs exclusive licensing and research collaboration with the University of California San Francisco. |
|
|
May 3, 2019 |
211 |
| Tmunity Therapeutics signs exclusive licensing and research collaboration with the University of California San Francisco. |
|
|
May 3, 2019 |
207 |
| Seattle Genetics: Health Canada approves use of Adcetris, AVD chemotherapy. |
|
|
May 3, 2019 |
126 |
| United States : Kite Announces Plans for New State-of-the-Art Facility to Expand Cell Therapy Production Capabilities. |
|
|
May 2, 2019 |
219 |
| LineaRx Achieves Higher Expression and Survival Rates in Human T Cells Transfected Non-Virally with Linear DNA. |
|
|
May 1, 2019 |
656 |
| Celgene, bluebird bio report interim results from CRB-401 study. |
|
|
May 1, 2019 |
441 |
| Raised levels of IFN-gamma and IL-13 are associated with pre-diabetes amongst newly diagnosed patients with Tuberculosis. |
|
Report |
Apr 30, 2019 |
4095 |
| HYPER IMMUNOGLOBULIN E IGE SYNDROME (HIES) WITH PARTIAL T LYMPHOCYTES DEFICIENCY. |
|
|
Apr 30, 2019 |
1431 |
| Kite Plans New Facility to Expand Cell Therapy Production Capabilities. |
|
|
Apr 29, 2019 |
251 |
| LineaRX says Avectas collaboration leads to increase in transfection. |
|
|
Apr 29, 2019 |
278 |
| Genexine, NeoImmuneTech Dose First Patient in the Combination Trial of Hyleukin-7 with Merck's Keytruda in Triple-Negative Breast Cancer. |
|
|
Apr 29, 2019 |
699 |
| Kite plans for new Maryland facility. |
|
|
Apr 26, 2019 |
208 |
| Kite plans for new Maryland facility. |
|
|
Apr 26, 2019 |
204 |
| Gilead Sciences (NASDAQ: GILD) - Kite Announces Plans for New State-of-the-Art Facility to Expand Cell Therapy Production Capabilities -- 24/4/2019. |
|
|
Apr 25, 2019 |
1317 |
| TC BioPharm Initiates Phase I Trial of Allogeneic Gamma Delta T Cell Therapy in Acute Myeloid Leukemia Patients. |
|
|
Apr 25, 2019 |
445 |
| Creating a bovine C-type lectin receptor atlas and identification of their ligands. |
|
|
Apr 25, 2019 |
377 |
| United States : St. Jude gene therapy cures babies with 'bubble boy' disease. |
|
|
Apr 20, 2019 |
773 |
| Belgium : Janssen Announces Investigational CAR-T Therapy JNJ-68284528 Granted PRIME Designation by the European Medicines Agency. |
|
|
Apr 20, 2019 |
420 |
| Precision BioSciences doses first patient in PBCAR0191 Phase 1/2a clinical trial. |
|
|
Apr 17, 2019 |
161 |
| Tessa partners with Merck to evaluate its human papillomavirus-specific T cell (HPVST) therapy & KEYTRUDA combination for cervical cancer. |
|
|
Apr 16, 2019 |
318 |
| Tessa partners with Merck to evaluate its human papillomavirus-specific T cell (HPVST) therapy & KEYTRUDA combination for cervical cancer. |
|
|
Apr 16, 2019 |
314 |
| Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. |
|
|
Apr 15, 2019 |
600 |
| Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. |
|
|
Apr 15, 2019 |
600 |
| Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. |
|
|
Apr 15, 2019 |
600 |
| Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. |
|
|
Apr 15, 2019 |
600 |
| Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. |
|
|
Apr 15, 2019 |
600 |
| Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. |
|
|
Apr 15, 2019 |
600 |
| Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. |
|
|
Apr 15, 2019 |
600 |
| Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. |
|
|
Apr 15, 2019 |
600 |
| Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. |
|
|
Apr 15, 2019 |
600 |
| Allogene Therapeutics announces publication of ALLO-715 study results. |
|
Report |
Apr 15, 2019 |
131 |
| Takara Bio submits Drug Master File to FDA for RetroNectin GMP grade liquid format for development of cancer immunotherapies. |
|
|
Apr 12, 2019 |
157 |
| Takara Bio submits Drug Master File to FDA for RetroNectin GMP grade liquid format for development of cancer immunotherapies. |
|
|
Apr 12, 2019 |
161 |
| Applied DNA's LineaRx achieves anti-CD19 CAR expression in human T cells. |
|
|
Apr 8, 2019 |
186 |
| Janssen's Investigational CAR-T Therapy JNJ-68284528 Granted PRIME Designation by the European Medicines Agency. |
|
|
Apr 8, 2019 |
560 |
| Immunomic Therapeutics Presents Late-Breaking Preclinical Data on DNA Vaccine ITI-7000 at AACR 2019. |
|
|
Apr 4, 2019 |
584 |
| IMV Inc. presents preclinical research for immunotherapy program at AACR. |
|
|
Apr 3, 2019 |
303 |
| Contract Manufacturing Organization For Advanced Therapy Medicinal Products (atimp). |
|
|
Apr 3, 2019 |
468 |
| Inovio says dBiTEs generated potent anti-tumor activities in preclinical study. |
|
Report |
Apr 2, 2019 |
142 |
| Aptevo Therapeutics presents preclinical data on APVO436, ALG.APV-527 at AACR. |
|
Clinical report |
Apr 2, 2019 |
359 |
| Jounce Therapeutics reports new clinical data on vopratelimab. |
|
|
Apr 2, 2019 |
355 |
| Imbrium Therapeutics Gains US FDA Orphan Drug Designation for Tinostamustine for the Treatment of T-cell Prolymphocytic Leukemia. |
|
|
Apr 2, 2019 |
592 |
| TC BioPharm welcomes John Anderson as scientific and medical director. |
|
|
Apr 1, 2019 |
176 |
| TC BioPharm welcomes John Anderson as scientific and medical director. |
|
|
Apr 1, 2019 |
172 |
| Iovance Biotherapeutics presents data on T-cell diversity at AACR meeting. |
|
Clinical report |
Apr 1, 2019 |
164 |
| Fate Therapeutics presents data on clonal master engineered iPSC lines. |
|
|
Apr 1, 2019 |
145 |
| Comparison of Antiretroviral Therapy Regimens With Regard to Virological and Immunological Response in Treatment-Naive HIV/AIDS Patients/Tedavi Naif HIV/AIDS Hastalarinda Kullanilan Antiretroviral Tedavi Rejimlerinin Virolojik ve Immunolojik Yanit Acisindan Karsilastirilmasi. |
Akkaya-Isik, Sinem; Gunduz, Alper; Oncul, Ahsen; Hamidi, Aziz Ahmad; Yildiz-Sevgi, Dilek; Kes-Uzun, |
|
Apr 1, 2019 |
4233 |
| Sheba, Lonza Collaborate on Cell Therapy Mfg. Platform. |
|
|
Apr 1, 2019 |
172 |
| Atara's collaborator presents Phase 1 study results in Advanced Mesothelioma. |
|
|
Mar 31, 2019 |
373 |
| Boy fighting rare cancer finally finds stem cell donor match after 10,000 offers; Oscar Saxelby-Lee was in a race against time to find a life-saving match after he was diagnosed with rare cancer T-cell acute lymphoblastic leukaemia (T-ALL). |
|
|
Mar 30, 2019 |
526 |
| Advaxis Granted US Patent Relating to Axalimogene Filolisbac. |
|
|
Mar 26, 2019 |
400 |
| Lead Pharma triggers fourth milestone payment under its license & collaboration agreement with Sanofi. |
|
|
Mar 21, 2019 |
234 |
| Crimson Trace CTL-3420 4-20X 50mm. |
Hutchcroft, Joel J. |
Product/service evaluation |
Mar 20, 2019 |
419 |
| The integration of human T cell senescence and function at the molecular level. |
|
|
Mar 18, 2019 |
517 |
| Exploring the role of T cells in the immune surveillance of early renal cancer. |
|
|
Mar 13, 2019 |
544 |
| United States : Cancer Therapy Company Cellectis to Establish Manufacturing Operations in North Carolina. |
|
|
Mar 8, 2019 |
741 |
| Germany : New immune therapy for treating cancer. |
|
|
Mar 7, 2019 |
762 |
| Design, Transfer and Qualification of a Commercially-Scalable Process for Viral Vectors. |
|
|
Mar 5, 2019 |
201 |
| Level of serum soluble Tim-3 expression in early-phase acute pancreatitis. |
Lin, Min; Huang, Jin; Huang, Jian; Liu, Sheng-lan; Chen, Wei-Chang |
Report |
Mar 1, 2019 |
2921 |
| Hidradenitis suppurativa linked to increased lymphoma risk. |
Sullivan, Michele G. |
|
Mar 1, 2019 |
432 |
| Nektar 'excited' by preliminary data from REVEAL study. |
|
|
Mar 1, 2019 |
205 |
| SARTORIUS BIOSTAT SINGLE-USE BIOREACTOR. |
|
|
Mar 1, 2019 |
379 |
| Sartorius Launches BIOSTAT Single-Use Bioreactor: Constantia Flexibles introduces Flexible Blister packaging. |
|
|
Mar 1, 2019 |
382 |
| New Way in Cancer Therapy: PD-1 Inhibitors and Hematologic Diseases. |
Akyol, Gulsah; Kaynar, Leylagul; Cetin, Mustafa |
Report |
Mar 1, 2019 |
4443 |
| SLC30A8 Gene rs13266634 C/T Polymorphism in Children with Type 1 Diabetes in Tamil Nadu, India. |
Thirunavukkarasu, Ramasamy; Asirvatham, Arthur Joseph; Chitra, Ayyappan; Jayalakshmi, Mariakuttikan |
Report |
Mar 1, 2019 |
3492 |
| Cutaneous Pseudolymphoma Due to Hirudotherapy/Hirudoterapiye Bagli Kutanoz Psodolenfoma. |
Temiz, Selami Aykut; Ozer, Ilkay; Ataseven, Arzu; Dursun, Recep; Findik, Siddika |
Case study |
Mar 1, 2019 |
1479 |
| Cell Medica Awarded 8.7m CPRIT Grant to Accelerate CMD-502 Off-the-shelf CAR-NKT Cell Therapy into Clinical Development. |
|
|
Feb 27, 2019 |
546 |
| TC BioPharm Partners & Trinity College Dublin partnership to develop V Delta 1 I[superscript three]I' T cell-based cancer treatments. |
|
|
Feb 25, 2019 |
195 |
| TC BioPharm Partners & Trinity College Dublin partnership to develop V Delta 1 I[superscript three]I' T cell-based cancer treatments. |
|
|
Feb 25, 2019 |
191 |
| Mallinckrodt announces research collaboration agreement with Transimmune AG. |
|
|
Feb 25, 2019 |
124 |
| Effect of antigen dose on T cells that signal via pSTAT but that are unresponsive to JAK inhibition a mechanism of T cell autoimmune activation. |
|
|
Feb 23, 2019 |
108 |
| Regulatory T cell Immunobiology Specialization and Stability in mucosal immunoregulation and tissue homestasis. |
|
|
Feb 23, 2019 |
108 |
| United States : Provectus Announces Grant of Orphan Drug Designation in U.S. to PV-10 for Treatment of Ocular Melanoma. |
|
|
Feb 23, 2019 |
365 |
| The Complement System and iNKT Cell Response. |
|
|
Feb 22, 2019 |
471 |
| Germany : Salt could be a key factor. |
|
|
Feb 22, 2019 |
360 |
| Mallinckrodt elects to discontinue further enrollment in Uvadex, Therakos trial. |
|
|
Feb 20, 2019 |
232 |
| Expensive CAR-T Cancer Therapy Could Be Part Of Medicare Coverage. |
|
|
Feb 20, 2019 |
290 |
| Autolus says updated CARPALL trial results confirm AUTO1 data from ASH 2017. |
|
|
Feb 19, 2019 |
394 |
| 'Killer' cells raise hope of universal flu vaccine. |
|
|
Feb 19, 2019 |
370 |
| Germany : Loss of identity in immune cells explained. |
|
|
Feb 19, 2019 |
491 |
| T cells in tuberculosis: What type of T cell mediates immunity and how do we induce it by vaccination. |
|
|
Feb 15, 2019 |
427 |
| NeoTX Therapeutics signs clinical collaboration with MedImmune. |
|
|
Feb 13, 2019 |
240 |
| Researchers find clues to a functional HIV cure. |
|
|
Feb 8, 2019 |
377 |
| Cytonus Develops New Cell-Based Technology to Advance the Fight against Cancer and Inflammatory Diseases. |
|
|
Feb 6, 2019 |
346 |
| Renewable Source Of Cancer-Fighting T Cells From New Technique. |
|
|
Feb 4, 2019 |
679 |
| Renewable Source Of Cancer-Fighting T Cells From New Technique. |
|
|
Feb 4, 2019 |
585 |
| Single mom appeals anew for cancer-stricken son. |
|
|
Feb 4, 2019 |
250 |
| Researchers find new clues to control HIV. |
|
|
Feb 2, 2019 |
616 |
| Tissue Resident Memory (Trm) CD8+ T cells: Genome-wide dissection of cellular differentiation and heterogeneity. |
|
|
Feb 2, 2019 |
327 |
| Integration and adaptation of impaired mitochondrial fitness in orchestrating T cell dysfunction in the tumor microenvironment. |
|
|
Feb 2, 2019 |
327 |
| Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology. |
|
|
Feb 2, 2019 |
350 |
| USFDA approves Eureka Therapeutics investigational new drug for ET140202 ARTEMIS T-cell therapy. |
|
|
Feb 1, 2019 |
157 |
| USFDA approves Eureka Therapeutics investigational new drug for ET140202 ARTEMIS T-cell therapy. |
|
|
Feb 1, 2019 |
153 |
| Engineering a Complex TCR Immunotherapy. |
|
|
Feb 1, 2019 |
508 |
| FDA CLEARS ET140202 ARTEMIS T-CELL THERAPY TRIAL. |
|
|
Feb 1, 2019 |
388 |
| Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans. |
McElroy, Anita K.; Shrivastava-Ranjan, Punya; Harmon, Jessica R.; Martines, Roosecelis B.; Silva-Fla |
Report |
Feb 1, 2019 |
6211 |
| The effect of nanoemulsified methionine and cysteine on the in vitro expression of casein in bovine mammary epithelial cells. |
Kim, Tae-Il; Kim, Tae-Gyun; Lim, Dong-Hyun; Kim, Sang-Bum; Park, Seong-Min; Lim, Hyun-Joo; Kim, Hyun |
Report |
Feb 1, 2019 |
4335 |
| Six-year-old boy with mediastinal mass. |
Rehman, Palwasha; Wali, Rabia Muhammad |
Clinical report |
Jan 31, 2019 |
474 |
| Manipulating myeloid cells to improve cancer immunotherapy. |
|
|
Jan 31, 2019 |
258 |
| Boy, 11, given new genetic cancer drug. |
|
|
Jan 31, 2019 |
130 |
| Seattle Genetics label expansion likely to drive Q4 beat, says Piper Jaffray. |
|
|
Jan 29, 2019 |
117 |
| The Effect of TAX-1 Gene of Human T-cell Leukemia Virus Type-1 on the Expression of CCR5 in K562 Cell Line. |
Sadaghiani, Nasrin Haghnazari; Pirayeshfard, Lila; Aghaie, Afsaneh; Sharifi, Zohreh |
Report |
Jan 1, 2019 |
2910 |
| Navigating the road to digital supply chain transformation. |
Saenz, Maria Jesus; Cottrill, Ken |
|
Jan 1, 2019 |
1355 |
| Doc: We're fighting cancer..and chemo; Irish expert says our own immune cells are key to conquering disease. |
|
|
Dec 16, 2018 |
434 |
| Bellicum Pharmaceuticals reports data from BPX-601 at ESMO-IO. |
|
|
Dec 14, 2018 |
277 |
| Aptevo Therapeutics doses first patient in Phase 1/1b trial of APVO436. |
|
|
Dec 13, 2018 |
151 |
| Bristol-Myers enters new clinical collaboration with Vedanta Biosciences. |
|
|
Dec 10, 2018 |
102 |
| United States : Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers. |
|
|
Dec 10, 2018 |
434 |
| United States : Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas. |
|
|
Dec 8, 2018 |
715 |
| iCell Gene Therapeutics Presents First-in-Human Data of CLL1-CD33 Compound CAR T in Refractory Acute Myeloid Leukemia. |
|
|
Dec 7, 2018 |
409 |
| Bluebird bio and Celgene Present Initial Data from Ongoing Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy bb21217 in Patients with Relapsed/Refractory Multiple Myeloma. |
|
|
Dec 6, 2018 |
754 |
| Unum Therapeutics receives patent for ACTR platform from USPTO. |
|
|
Dec 6, 2018 |
111 |
| Amgen says AMG420 receives FDA fast track designation. |
|
|
Dec 4, 2018 |
281 |
| Seattle Genetics' T-cell lymphoma data best case scenario, says William Blair. |
|
|
Dec 4, 2018 |
119 |
| Fate Therapeutics announces preclinical data on iPSC product platform at ASH. |
|
|
Dec 4, 2018 |
385 |
| UK's AFH Wealth Management reports asset increase. |
|
|
Dec 3, 2018 |
241 |
| AbCellera collaborates with Autolus Therapeutics. |
|
|
Dec 3, 2018 |
238 |
| UK's AFH Wealth Management reports asset increase. |
|
|
Dec 3, 2018 |
239 |
| AbCellera collaborates with Autolus Therapeutics. |
|
|
Dec 3, 2018 |
234 |
| VINETI PARTNERS WITH TESSA THERAPEUTICS. |
|
|
Dec 1, 2018 |
783 |
| Fitch Ratings affirms Catchment Tay Limited's notes. |
|
|
Dec 1, 2018 |
314 |
| Clinical flow assay. |
|
|
Dec 1, 2018 |
104 |
| Term ve gec preterm bebeklerde gobek kordonu klempleme zamaninin lenfosit alt gruplari uzerine etkisi/The effects of umblical cord clamping time on lymphocyte subgroups in term and late preterm infants. |
Bahar, Nilgun; Satar, Mehmet; Yilmaz, Mustafa; Buyukkurt, Selim; Ozlu, Ferda; Yildizdas, Hacer Yapic |
Report |
Dec 1, 2018 |
5124 |
| Fitch Affirms Catchment Tay Limited's Notes at 'BBB-'; Outlook Stable. |
|
|
Nov 30, 2018 |
967 |
| Impact of T lymphocytes on clinical disease, immune responses and transmission of bluetongue virus in sheep. |
|
|
Nov 29, 2018 |
281 |
| Dissecting the role of TGF-beta+ regulatory CD4+ T cells in pathogenesis of Marek's disease in chickens. |
|
|
Nov 29, 2018 |
331 |
| Kura Oncology announces new patent for tipifarnib from USPTO. |
|
|
Nov 28, 2018 |
160 |
| Celgene, bluebird bio Complete Enrollment of Pivotal KarMMa Study of anti-BCMA Car T Cell Therapy bb2121 in Patients with Relapsed and Refractory Multiple Myeloma. |
|
|
Nov 28, 2018 |
396 |
| How salt can trigger inflammation in multiple sclerosis. |
|
|
Nov 25, 2018 |
469 |
| Vineti & Tessa Therapeutics partnership to advance and scale cancer immunotherapies world-wide. |
|
|
Nov 23, 2018 |
195 |
| Service Of Immunosuppression Of Cell Receptors B (bcrs) And T Cell Receptors (tcrs) By Means Of A New Generation Sequencing Platform, Destined For The Research Group Of Systemic Diseases Of The University Hospital Foundation Hebron Valley - Research Insti. |
|
|
Nov 21, 2018 |
151 |
| The US FDA approves first-line treatment Adcetris for peripheral T-cell lymphoma under new review pilot. |
|
|
Nov 19, 2018 |
266 |
| The US FDA approves first-line treatment Adcetris for peripheral T-cell lymphoma under new review pilot. |
|
|
Nov 19, 2018 |
262 |
| Atara Biotherapeutics announces publication of Phase 1 ATA190 results. |
|
Financial report |
Nov 19, 2018 |
290 |
| FDA Grants Breakthrough Therapy Designation to Adcetris for Frontline Peripheral T-Cell Lymphomas. |
|
|
Nov 19, 2018 |
1245 |
| Fundit: Functional diversity of t cells. |
|
|
Nov 17, 2018 |
378 |
| Cor1-tcell: Analysis of the role for coronin 1-dependent cell density signalling in t-cell homeostasis. |
|
|
Nov 17, 2018 |
357 |
| Mechanoimm: Mechanical immunoengineering for enhanced t-cell immunotherapy. |
|
|
Nov 17, 2018 |
361 |
| United States : Seattle Genetics Announces FDA Approval of ADCETRIS (Brentuximab Vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas. |
|
|
Nov 17, 2018 |
776 |
| United States : FDA Grants Breakthrough Therapy Designation to ADCETRIS (Brentuximab Vedotin) for Frontline Peripheral T-Cell Lymphomas. |
|
|
Nov 17, 2018 |
615 |
| United States : Sprint to Launch All-New Sprint LTE Chromebook by CTL for Education and Business Customers. |
|
|
Nov 17, 2018 |
402 |
| Probiotics can help increase bone density: Study. |
|
|
Nov 16, 2018 |
360 |
| Amgen receives positive CHMP opinion to expand use of BLINCYTO. |
|
Clinical report |
Nov 16, 2018 |
104 |
| Seattle Genetics announces FDA approval of ADCETRIS. |
|
|
Nov 16, 2018 |
478 |
| Probiotics can help increase bone density: Study. |
|
|
Nov 16, 2018 |
318 |
| Seattle Genetics receives Breakthrough Therapy Designation for ADCETRIS. |
|
|
Nov 15, 2018 |
309 |
| Probiotics can help increase bone density. |
|
|
Nov 15, 2018 |
352 |
| Harpoon Therapeutics Launches ProTriTAC Platform: A Novel, Protease-Activated T Cell Engager Platform Designed to Access a Broad Landscape of Solid Tumor Targets. |
|
|
Nov 14, 2018 |
468 |
| Probiotics can help increase bone density: Study. |
|
|
Nov 14, 2018 |
331 |
| Harpoon Therapeutics completes USD70m series C equity financing. |
|
|
Nov 13, 2018 |
181 |
| Harpoon Therapeutics completes USD70m series C equity financing. |
|
|
Nov 13, 2018 |
177 |
| Compugen announces issuance of U.S. patent for COM902. |
|
|
Nov 13, 2018 |
139 |
| Cesca Therapeutics subsidiary filed MAF with FDA. |
|
|
Nov 13, 2018 |
104 |
| Obsidian Presents Preclinical Data Demonstrating Precise Regulation of Cytokines and CAR in T cells with Destabilizing Domain Technology using FDA-Approved Drugs. |
|
|
Nov 13, 2018 |
447 |
| Ziopharm, Regeneron announce clinical supply agreement for rGBM treatment. |
|
|
Nov 12, 2018 |
191 |
| Jounce Therapeutics presents data from ICOS program at SITC annual meeting. |
|
|
Nov 11, 2018 |
340 |
| OncoMed announces early clinical data for anti-TIGIT antibody. |
|
|
Nov 9, 2018 |
230 |
| Cue Biopharma presents foundational data on Immuno-STAT platform and CUE-101. |
|
|
Nov 9, 2018 |
219 |
| Vedanta Biosciences Touts Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate. |
|
|
Nov 9, 2018 |
567 |
| Sensei Biotherapeutics Presents Clinical Trial Data Demonstrating SNS-301 Induces Rapid and Robust Antigen-specific Immune Responses. |
|
|
Nov 9, 2018 |
743 |
| US FDA receives supplemental Biologics License Application for Seattle Genetics' Adcetris. |
|
|
Nov 7, 2018 |
194 |
| US FDA receives supplemental Biologics License Application for Seattle Genetics' Adcetris. |
|
|
Nov 7, 2018 |
190 |
| Seattle Genetics Submits Supplemental Biologics License Application for Adcetris (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas. |
|
|
Nov 7, 2018 |
480 |
| Provectus says FDA grants orphan drug designation to PV-10 for neuroblastoma. |
|
|
Nov 5, 2018 |
131 |
| Seattle Genetics submits supplemental BLA for ADCETRIS. |
|
|
Nov 5, 2018 |
242 |
| United States : Janssen Shows Commitment to Advancing the Science and Treatment of Blood Cancers and Related Conditions With More Than 80 ASH 2018 Data Presentations From Differentiated Oncology and Cardiovascular Portfolios. |
|
|
Nov 5, 2018 |
666 |
| T-cell lymphoma with rhabdomyolysis: case report and literature review. |
Ouyang, Zhao-Zhong; Peng, Ting-Sheng; Cao, Qing-Hua; Ouyang, Yin; Li, Jun-Xun; Wei, Qiu-Xiang; Zhan, |
Case study |
Nov 1, 2018 |
1550 |
| Kikuchi-Fujimoto Disease: A Review. |
Perry, Anamarija M.; Choi, Sarah M. |
Report |
Nov 1, 2018 |
3487 |
| Update on Gastrointestinal Lymphomas. |
Weindorf, Steven C.; Smith, Lauren B.; Owens, Scott R. |
Report |
Nov 1, 2018 |
3437 |
| Primary Cutaneous Composite Lymphomas. |
Chen, Stephanie; Boyer, Daniel; Hristov, Alexandra C. |
Report |
Nov 1, 2018 |
2922 |
| Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma. |
Monroig-Bosque, Paloma del C.; Driver, Brandon; Morales-Rosado, Joel A.; Deavers, Michael; Tacha, Da |
Report |
Nov 1, 2018 |
4002 |
| Assessing and screening for T-cell epitopes from Mycobacterium tuberculosis RD2 proteins for the diagnosis of active tuberculosis. |
Chen, Jiazhen; Ruan, Qiaoling; Shen, Yaojie; Wang, Sen; Shao, Lingyun; Zhang, Wenhong |
|
Nov 1, 2018 |
5820 |
| Human T cell lymphotropic virus type 1 infection among men who have sex with men in Central Brazil. |
Castro, Lisie Souza; Rezende, Grazielli Rocha de; Fernandes, Fernanda Rodas Pires; Bandeira, Larissa |
|
Nov 1, 2018 |
3398 |
| Effects of Topical Thymoquinone in an Experimental Dry Eye Model. |
Kocaturk, Tolga; Erkan, Erol; Meteoglu, Ibrahim; Ekici, Mehmet; Buyukozturk, Aslihan Karul; Yavasogl |
|
Nov 1, 2018 |
4954 |
| City of Hope opens CAR T trial for patients with HER2-positive breast cancer. |
|
|
Oct 30, 2018 |
225 |
| Mustang Bio announces initiation of Phase 1 in HER2-positive breast cancer. |
|
|
Oct 30, 2018 |
228 |
| NanoString, MacroGenics enter translational research collaboration. |
|
|
Oct 29, 2018 |
170 |
| How insulin boosts immune system. |
|
|
Oct 25, 2018 |
406 |
| Adaptimmune presents updated data from ongoing MAGE-A10, MAGE-A4 studies. |
|
|
Oct 21, 2018 |
413 |
| BioLineRx discloses additional data from Phase 2a COMBAT/KEYNOTE-202 study. |
|
|
Oct 21, 2018 |
244 |
| G1 presents additional data from randomized Phase 2 trial in first-line SCLC. |
|
|
Oct 21, 2018 |
161 |
| Fine Particulate Matter-Induced Exacerbation of Allergic Asthma via Activation of T-cell Immunoglobulin and Mucin Domain 1. |
Zhao, Yun-Xia; Zhang, Hui-Ran; Yang, Xiu-Na; Zhang, Yu-Hao; Feng, Shan; Yu, Feng-Xue; Yan, Xi-Xin |
Report |
Oct 20, 2018 |
10257 |
| United Kingdom,United States : First neuroblastoma patient successfully dosed with innovative CAR therapy utilizing natural killer T cells (CAR-NKT). |
|
|
Oct 20, 2018 |
254 |
| Innovent Biologics Inc treats first patient in phase I clinical trial of anti-CTLA-4 monoclonal antibody (IBI310). |
|
|
Oct 19, 2018 |
208 |
| Innovent Biologics Inc treats first patient in phase I clinical trial of anti-CTLA-4 monoclonal antibody (IBI310). |
|
|
Oct 19, 2018 |
204 |
| Five Prime Therapeutics Initiates Patient Dosing in The Dose Exploration Cohort of Its Phase 1 Trial of Novel First-in-class B7-H4 Antibody FPA150. |
|
|
Oct 18, 2018 |
441 |
| Applied DNA Sciences subsidiary LineaRx licenses CAR T candidate. |
|
|
Oct 16, 2018 |
109 |
| Five Prime initiates patient dosing in dose exploration cohort of Phase 1 trial. |
|
|
Oct 16, 2018 |
258 |
| Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-Viral, Plasmid-Free CAR T Manufacturing Platform. |
|
|
Oct 16, 2018 |
393 |
| Soligenix receives DMC recommendation to enroll more subjects in FLASH study. |
|
|
Oct 15, 2018 |
310 |
| Athenex announces preliminary results from TAEST pilot studies. |
|
|
Oct 15, 2018 |
359 |
| United States : Ziopharm and Precigen Redefine Relationships, Announce New License Agreement. |
|
|
Oct 15, 2018 |
643 |
| Palmer: PRV-031 could be first ever disease modifying type 1 diabetes therapy. |
|
|
Oct 11, 2018 |
314 |
| G1 Therapeutics announces new data from Phase 2 trilaciclib trial at ESMO. |
|
|
Oct 9, 2018 |
120 |
| Ziopharm, Intrexon subsidiary announce new definitive license agreement. |
|
|
Oct 9, 2018 |
246 |
| Supply Of 1 Cell Processing Equipment And Consumables Necessary For The Automated Manufacture Of Cart-t Cells And Other Cell Therapy Products In Banco Sangre Tejidos Cantabria. |
|
|
Oct 9, 2018 |
149 |
| FDA puts Affimed N.V.'s AFM11 phase 1 program on hold following death of patient. |
|
|
Oct 8, 2018 |
212 |
| Adaptimmune to present updates from MAGE-A10 studies at ESMO. |
|
|
Oct 8, 2018 |
165 |
| United States : Seattle Genetics and Takeda Announce Positive Results from Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS (Brentuximab Vedotin) in Frontline CD30-Expressing Peripheral T-Cell Lymphoma. |
|
Financial report |
Oct 6, 2018 |
716 |
| Daiichi Sankyo's axicabtagene ciloleucel granted Orphan Drug designation by Japanese Ministry. |
|
|
Oct 4, 2018 |
205 |
| Daiichi Sankyo's axicabtagene ciloleucel granted Orphan Drug designation by Japanese Ministry. |
|
|
Oct 4, 2018 |
201 |
| PD-L1 Biomarker Testing Market Higher Mortality Rates by 2027. |
|
|
Oct 4, 2018 |
1179 |
| PD-L1 Biomarker Testing Market to Gain a Stronghold by 2027. |
|
|
Oct 4, 2018 |
1179 |
| PD-L1 Biomarker Testing Market Likely to Emerge over a Period of 2017-2027. |
|
|
Oct 4, 2018 |
1179 |
| IBBR receives $1.2M NIH award to develop 3D modeling tool. |
|
|
Oct 3, 2018 |
252 |
| United States : Kite and HiFiBiO Therapeutics Announce a Research Collaboration to Develop Technology for the Potential Discovery of Neoantigen-Reactive T Cell Receptors (TCRs) for the Treatment of Cancer. |
|
|
Oct 3, 2018 |
322 |
| Kite, HiFiBiO announce research collaboration. |
|
|
Oct 2, 2018 |
186 |
| Inovio spikes higher after positive data published. |
|
|
Oct 2, 2018 |
332 |
| Seattle Genetics, Takeda Tout Positive Results from Phase 3 ECHELON-2 Clinical Trial Evaluating Adcetris in Frontline CD30-Expressing Peripheral T-Cell Lymphoma. |
|
|
Oct 2, 2018 |
1050 |
| Actinium Pharmaceuticals launches Iomab-ACT program. |
|
|
Oct 1, 2018 |
157 |
| KSQ Therapeutics Secures USD 80m Financing and Advances Pipeline of Cancer Therapies. |
|
|
Oct 1, 2018 |
536 |
| Candidiasis mucocutanea cronica: una mirada al entendimiento genetico. |
Maya-Rico, Ana Maria; Cardona-Castro, Nora |
|
Oct 1, 2018 |
3585 |
| Fate, ONO Pharmaceutical. |
|
|
Oct 1, 2018 |
323 |
| St. Jude Children's Research Hospital and Tessa Therapeutics Announce Strategic Collaboration. |
|
|
Sep 30, 2018 |
596 |
| Chimeric Antigen Receptor (CAR) T-cell therapy; a promising outlook for refractory malignancies. |
|
|
Sep 30, 2018 |
797 |
| First Patient Dosed With FLX475, an CCR4 Inhibitor for the Treatment of Multiple Cancers. |
|
|
Sep 28, 2018 |
483 |
| United States : BLINCYTO (blinatumomab) Approved In Japan For The Treatment Of Relapsed Or Refractory B-cell Acute Lymphoblastic Leukemia. |
|
|
Sep 27, 2018 |
640 |
| Cellular signs licensing and collaboration agreement with Novartis in China. |
|
|
Sep 27, 2018 |
114 |
| Terex extends maximum jib length with new luffer tower crane. |
|
|
Sep 26, 2018 |
552 |
| Regen BioPharma announces activation of immune cells by NR2F6. |
|
|
Sep 24, 2018 |
178 |
| Regen BioPharma announces activation of immune cells by NR2F6. |
|
|
Sep 24, 2018 |
174 |
| Cancer Immunotherapy: Overlooked Immune Players. |
|
|
Sep 24, 2018 |
1107 |
| Supply Of Human Cd4 Microbeads, 2ml, Humancd45ra Microbeads, 2ml, Cd4 T Cell Isolation Kit, Mouse And Bdca4/neutropilin 1 Microbead Kit, Human. |
|
|
Sep 21, 2018 |
150 |
| Fate Therapeutics to partner with ONO Pharma on Car-T cell immunotherapy. |
|
|
Sep 17, 2018 |
232 |
| Innovent Biologics treats first patient under phase III clinical trial of sintilimab for non-squamous non-small cell lung cancer (NSCLC). |
|
|
Sep 11, 2018 |
266 |
| Innovent Biologics treats first patient under phase III clinical trial of sintilimab for non-squamous non-small cell lung cancer (NSCLC). |
|
|
Sep 11, 2018 |
262 |
| Amgen's AMG420 risk overstated, says Wells Fargo. |
|
|
Sep 11, 2018 |
156 |
| Triumvira Inks License Agreement with University of Toronto for the Discovery of Antibody Drug Development Candidates. |
|
|
Sep 10, 2018 |
401 |
| T cell behavior has major implications for cancer immunotherapy. |
|
|
Sep 8, 2018 |
523 |
| Protein that enhances vaccine efficacy identified. |
|
|
Sep 8, 2018 |
332 |
| Biothera Pharmaceuticals enters into collaboration with AstraZeneca. |
|
|
Sep 7, 2018 |
180 |
| Biothera Pharmaceuticals enters into collaboration with AstraZeneca. |
|
|
Sep 7, 2018 |
176 |
| 'Game changing' cancer therapy on offer in Newcastle. |
|
|
Sep 6, 2018 |
497 |
| Hospital to offer new leukaemia therapy. |
|
|
Sep 6, 2018 |
620 |
| Atara Biotherapeutics enters into CAR T collaboration with Moffitt Cancer Center. |
|
|
Sep 6, 2018 |
203 |
| Amedica sells spine business to CTL Medical for $10M. |
|
|
Sep 6, 2018 |
214 |
| Early Changes in Circulatory T Helper Type 1, 2, and 17 Cells of Patients with Out-of-Hospital Cardiac Arrest after Successful Cardiopulmonary Resuscitation. |
Qi, Zhi-Jiang; Zhang, Qiang; Liu, Bo; Shao, Huan; Li, Chun-Sheng |
Report |
Sep 5, 2018 |
5110 |
| Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation. |
Huang, Wen-Rong; Liu, Dai-Hong |
Report |
Sep 5, 2018 |
6001 |
| Pricy process is unique to each tumour. |
|
|
Sep 5, 2018 |
116 |
| NHS gives 'chance of a leukaemia cure to kids who have no other hope'. |
|
|
Sep 5, 2018 |
324 |
| Expensive as it is unique to each tumour. |
|
|
Sep 5, 2018 |
116 |
| Costly as it is tailor-made to each tumour. |
|
|
Sep 5, 2018 |
116 |
| Young cancer victims among first to get pioneering new treatment on NHS; The NHS is set to announce today that it will become the first health service in Europe to offer full access to the immunotherapy called CAR-T. |
|
|
Sep 5, 2018 |
482 |
| Aduro Biotech announces data publication on APRIL in MM in Leukemia. |
|
|
Sep 4, 2018 |
260 |
| Imbalance of [gamma][delta]T17/[gamma][delta]Treg cells in the pathogenesis of allergic asthma induced by ovalbumin. |
Yang, Xia; Zhang, Jing-Hong; Deng, Wang-Sheng; Li, Chao-Qian |
Report |
Sep 1, 2018 |
3950 |
| Mycosis fungoides. |
Martin, Donna Bilu |
|
Sep 1, 2018 |
474 |
| Cutavirus shows no association with primary cutaneous lymphoma. |
Splete, Heidi |
|
Sep 1, 2018 |
245 |
| Mesenchymal stem cells prolong the survival of orthotopic liver transplants by regulating the expression of TGF-[beta]1. |
Niu, Jian; Wang, Yue; Liu, Bin; Yao, Yuanhu |
|
Sep 1, 2018 |
5197 |
| Perforation of the small intestine caused by enteropathy-associated T cell lymphoma. |
Kabul, Selva; Ugras, Nesrin; Yerci, Omer; Ozturk, Ersin |
|
Sep 1, 2018 |
1532 |
| HIV ile Enfekte Olgularin Bagirsak Protozoonlari Acisindan Retrospektif Olarak Incelenmesi/Intestinal Protozoa in HIV-infected Patients: A Retrospective Analysis. |
Zorbozan, Orcun; Quliyeva, Gunel; Tunali, Varol; Ozbilgin, Ahmet; Turgay, Nevin; Gokengin, Ayse Deni |
Report |
Sep 1, 2018 |
2390 |
| Regeneron, bluebird bio. |
|
|
Sep 1, 2018 |
343 |
| CTL: Thompson. |
|
|
Sep 1, 2018 |
113 |
| T cell reactivity to Collagen II as a possible prognostic marker in patients with rheumatoid arthritis. |
|
|
Aug 31, 2018 |
3675 |
| How insulin boosts immune system. |
|
|
Aug 31, 2018 |
406 |
| Singapore's First Clinical Trial Approval for T-cell Engineered (TCR) Immunotherapy for Treatment of Liver Cancer. |
|
|
Aug 31, 2018 |
475 |
| The European Commission approves Novartis' Kymriah CAR-T cell therapy. |
|
|
Aug 29, 2018 |
212 |
| The European Commission approves Novartis' Kymriah CAR-T cell therapy. |
|
|
Aug 29, 2018 |
208 |
| CStone receives CNDA approval for anti-CTLA-4 antibody CS1002. |
|
|
Aug 28, 2018 |
229 |
| CStone receives CNDA approval for anti-CTLA-4 antibody CS1002. |
|
|
Aug 28, 2018 |
225 |
| United States : Yescarta (Axicabtagene Ciloleucel) Receives European Marketing Authorization for the Treatment of Relapsed or Refractory DLBCL and PMBCL, After Two or More Lines of Systemic Therapy. |
|
|
Aug 28, 2018 |
521 |
| Novartis receives EC approval for Kymriah. |
|
|
Aug 27, 2018 |
129 |
| For hospitals, being first means they have what it takes. |
Daks, Martin |
|
Aug 27, 2018 |
1281 |
| Bluebird Bio and Gritstone Oncology Team to Develop Novel Cancer Cell Therapies. |
|
|
Aug 24, 2018 |
476 |
| Soligenix receives U.S. patent for synthetic hypericin used in SGX301. |
|
|
Aug 22, 2018 |
116 |
| Batu Biologics Identifies Gene Types Associated with Response to ValloVax. |
|
|
Aug 22, 2018 |
229 |
| Immunocore doses first patient in phase I study of IMCnyeso. |
|
|
Aug 21, 2018 |
181 |
| Immunocore doses first patient in phase I study of IMCnyeso. |
|
|
Aug 21, 2018 |
177 |
| Singapore's Health Sciences Authority approves Lion TCR's Phase I/II multicentre clinical study of LioCyx. |
|
|
Aug 20, 2018 |
169 |
| Lion TCR Pte Ltd approves first clinical trial for T cell engineered (TCR) immunotherapy in Singapore for treatment of liver cancer. |
|
|
Aug 20, 2018 |
284 |
| Singapore's Health Sciences Authority approves Lion TCR's Phase I/II multicentre clinical study of LioCyx. |
|
|
Aug 20, 2018 |
173 |
| Lion TCR Pte Ltd approves first clinical trial for T cell engineered (TCR) immunotherapy in Singapore for treatment of liver cancer. |
|
|
Aug 20, 2018 |
288 |
| Eureka Therapeutics Highlights Publication of Armored T-Cell Proof-of-Concept Study in Nature Biotechnology. |
|
|
Aug 20, 2018 |
530 |
| Study: Glaucoma may be an autoimmune disease. |
|
|
Aug 15, 2018 |
292 |
| Adaptimmune to initiate third dosing cohort in MAGE-A4 SPEAR T-cell study. |
|
|
Aug 15, 2018 |
114 |
| RXi Pharmaceuticals and Swedish institute partner to develop sd-rxRNA compounds. |
|
|
Aug 15, 2018 |
107 |
| Scancell Holdings, Karolinska Institute Sweden expand research collaboration. |
|
|
Aug 13, 2018 |
188 |
| Scancell Holdings, Karolinska Institute Sweden expand research collaboration. |
|
|
Aug 13, 2018 |
184 |
| Unum Therapeutics announces IND activation for ACTR T cells with trastuzumab. |
|
|
Aug 13, 2018 |
124 |
| United States : Bluebird Bio Forms Strategic Collaboration With Regeneron to Make New Cell Therapies for Cancer. |
|
|
Aug 13, 2018 |
221 |
| Glaucoma May Be an Autoimmune Disease. |
|
|
Aug 11, 2018 |
902 |
| Moleculin Biotech seeks approval from Polish agency for skin cancer trial. |
|
|
Aug 9, 2018 |
155 |
| Harpoon Therapeutics Treats First Patient with HPN424 in Phase 1 Clinical Trial of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients. |
|
|
Aug 9, 2018 |
439 |
| Ziopharm reports Q2 EPS (12c), consensus (12c). |
|
Financial report |
Aug 8, 2018 |
101 |
| Caramba: Slamf7-car t cells prepared by sleeping beauty gene-transfer for immunotherapy of multiple myeloma a rare hematologic disease. |
|
|
Aug 8, 2018 |
468 |
| Basilic: Decoding at systems-level the crosstalk between the t cell antigen receptor, The cd28 costimulator and the pd-1 coinhibitor under physiological and pathological conditions. |
|
|
Aug 7, 2018 |
385 |
| Germany : Can rare lymphocytes combat rheumatoid arthritis? |
|
|
Aug 7, 2018 |
564 |
| Regeneron, Bluebird Bio announce collaboration. |
|
|
Aug 6, 2018 |
254 |
| Miragen Therapeutics, LLS enter agreement to support development of cobomarsen. |
|
|
Aug 6, 2018 |
182 |
| CenturyLink authorised to operate under GSA Alliant 2. |
|
|
Aug 6, 2018 |
246 |
| CenturyLink authorised to operate under GSA Alliant 2. |
|
|
Aug 6, 2018 |
234 |
| CenturyLink authorised to operate under GSA Alliant 2. |
|
|
Aug 6, 2018 |
246 |
| New Combinations Of Immune-checkpoint Inhibitors To Treat Cancer. |
|
|
Aug 3, 2018 |
502 |
| Kite, Gadeta Forge Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors. |
|
|
Aug 2, 2018 |
463 |
| Gene linked to hair loss may improve cancer treatment. |
|
|
Aug 2, 2018 |
350 |
